Luna Awarded NIH Grant to Apply Nanotechnology to Allergy Treatment
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Luna Innovations Incorporated announces the award of a $1.6M Research Project Grant (R01) from the National Institutes of Health (NIH) to investigate the use of fullerene-based nanomedicines as a pathway to treat allergies and other inflammatory diseases.
This research program may offer a new therapeutic solution using fullerene compounds for treating allergies and other conditions that play a central role in inflammatory reactions, such as arthritis and multiple sclerosis. The study will include evaluating Luna’s exclusive nanomedicine prototypes.
